Biosenta Inc. (ZRO.CN)
CAD 0.26
(-3.7%)
CAD 0.26
(-3.7%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.51 Million CAD | 20.83% |
| 2022 | 1.19 Million CAD | -43.48% |
| 2021 | 2.11 Million CAD | 190.78% |
| 2020 | 728.64 Thousand CAD | 42.11% |
| 2019 | 512.74 Thousand CAD | 93.51% |
| 2018 | 264.97 Thousand CAD | -28.18% |
| 2017 | 368.92 Thousand CAD | -56.17% |
| 2016 | 841.67 Thousand CAD | -60.13% |
| 2015 | 2.11 Million CAD | -39.16% |
| 2014 | 3.46 Million CAD | 46.04% |
| 2013 | 2.37 Million CAD | 2.23% |
| 2012 | 2.32 Million CAD | 122.47% |
| 2011 | 1.04 Million CAD | 3524.36% |
| 2010 | 28.82 Thousand CAD | -15.28% |
| 2009 | 34.02 Thousand CAD | -78.34% |
| 2008 | 157.05 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 192.67 Thousand CAD | -23.9% |
| 2024 Q1 | 253.18 Thousand CAD | -37.69% |
| 2024 Q3 | 444.01 Thousand CAD | 130.81% |
| 2023 Q1 | 234.36 Thousand CAD | -17.6% |
| 2023 FY | 1.44 Million CAD | 20.83% |
| 2023 Q4 | 406.35 Thousand CAD | -15.29% |
| 2023 Q3 | 479.67 Thousand CAD | 46.91% |
| 2023 Q2 | 326.51 Thousand CAD | 39.32% |
| 2022 Q3 | 276.67 Thousand CAD | -7.97% |
| 2022 FY | 1.19 Million CAD | -43.48% |
| 2022 Q1 | 335.79 Thousand CAD | 5.32% |
| 2022 Q2 | 300.63 Thousand CAD | -10.47% |
| 2022 Q4 | 284.41 Thousand CAD | 2.8% |
| 2021 Q2 | 551.71 Thousand CAD | 51.77% |
| 2021 Q1 | 363.51 Thousand CAD | 35.04% |
| 2021 Q3 | 884.67 Thousand CAD | 60.35% |
| 2021 Q4 | 318.84 Thousand CAD | -63.96% |
| 2021 FY | 2.11 Million CAD | 190.78% |
| 2020 Q2 | 164.95 Thousand CAD | -8.33% |
| 2020 Q4 | 269.18 Thousand CAD | 134.94% |
| 2020 FY | 728.64 Thousand CAD | 42.11% |
| 2020 Q1 | 179.93 Thousand CAD | 15.57% |
| 2020 Q3 | 114.57 Thousand CAD | -30.54% |
| 2019 FY | 512.74 Thousand CAD | 93.51% |
| 2019 Q1 | 80.83 Thousand CAD | 42.03% |
| 2019 Q2 | 157.94 Thousand CAD | 95.4% |
| 2019 Q4 | 155.68 Thousand CAD | 31.61% |
| 2019 Q3 | 118.29 Thousand CAD | -25.1% |
| 2018 Q4 | 56.91 Thousand CAD | -2.43% |
| 2018 Q3 | 58.32 Thousand CAD | -26.27% |
| 2018 Q2 | 79.1 Thousand CAD | 12.01% |
| 2018 Q1 | 70.62 Thousand CAD | -11.32% |
| 2018 FY | 264.97 Thousand CAD | -28.18% |
| 2017 Q4 | 79.63 Thousand CAD | -27.11% |
| 2017 FY | 368.92 Thousand CAD | -56.17% |
| 2017 Q3 | 109.25 Thousand CAD | 27.72% |
| 2017 Q1 | 94.48 Thousand CAD | -16.92% |
| 2017 Q2 | 85.54 Thousand CAD | -9.46% |
| 2016 Q3 | 222.36 Thousand CAD | -16.45% |
| 2016 Q2 | 266.13 Thousand CAD | 7.61% |
| 2016 FY | 841.67 Thousand CAD | -60.13% |
| 2016 Q1 | 247.32 Thousand CAD | -38.04% |
| 2016 Q4 | 113.72 Thousand CAD | -48.86% |
| 2015 Q1 | 829.71 Thousand CAD | 25.95% |
| 2015 Q3 | 344.64 Thousand CAD | -35.87% |
| 2015 FY | 2.11 Million CAD | -39.16% |
| 2015 Q2 | 537.38 Thousand CAD | -35.23% |
| 2015 Q4 | 399.18 Thousand CAD | 15.82% |
| 2014 Q4 | 658.74 Thousand CAD | -9.91% |
| 2014 FY | 3.46 Million CAD | 46.04% |
| 2014 Q2 | 1.58 Million CAD | 218.77% |
| 2014 Q3 | 731.22 Thousand CAD | -53.81% |
| 2014 Q1 | 496.6 Thousand CAD | -35.03% |
| 2013 FY | 2.37 Million CAD | 2.23% |
| 2013 Q2 | 549.68 Thousand CAD | 3.81% |
| 2013 Q4 | 764.4 Thousand CAD | 43.65% |
| 2013 Q1 | 529.53 Thousand CAD | -42.22% |
| 2013 Q3 | 532.12 Thousand CAD | -3.19% |
| 2012 Q4 | 916.43 Thousand CAD | 89.65% |
| 2012 FY | 2.32 Million CAD | 122.47% |
| 2012 Q2 | 442.9 Thousand CAD | -8.0% |
| 2012 Q3 | 483.23 Thousand CAD | 9.1% |
| 2012 Q1 | 481.43 Thousand CAD | -39.12% |
| 2011 Q1 | 17.82 Thousand CAD | 201.86% |
| 2011 Q4 | 790.82 Thousand CAD | 314.55% |
| 2011 FY | 1.04 Million CAD | 3524.36% |
| 2011 Q3 | 190.76 Thousand CAD | 321.83% |
| 2011 Q2 | 45.22 Thousand CAD | 153.67% |
| 2010 FY | 28.82 Thousand CAD | -15.28% |
| 2010 Q2 | 2599.00 CAD | -84.04% |
| 2010 Q4 | 5906.00 CAD | 46.3% |
| 2010 Q3 | 4037.00 CAD | 55.33% |
| 2010 Q1 | 16.28 Thousand CAD | 380.58% |
| 2009 FY | 34.02 Thousand CAD | -78.34% |
| 2009 Q4 | 3388.00 CAD | -37.69% |
| 2009 Q3 | 5437.00 CAD | -73.09% |
| 2009 Q1 | 4990.00 CAD | -91.65% |
| 2009 Q2 | 20.2 Thousand CAD | 304.95% |
| 2008 Q2 | 33.54 Thousand CAD | 0.0% |
| 2008 Q3 | 38.74 Thousand CAD | 15.49% |
| 2008 Q4 | 59.75 Thousand CAD | 54.23% |
| 2008 FY | 157.05 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pure to Pure Beauty Inc. | 215.47 Thousand CAD | -600.945% |